Organisations are facing a patent cliff, healthcare reforms across key markets, and what many are calling an ‘innovation crisis’. All of this means the pressure is on for companies to meet the need for fast-paced development and change.
To adapt to new market dynamics and satisfy investor demands for performance, organisations need to build strong innovation pipelines and operate in a more agile, outward-looking way. It’s not enough to merely boast efficient processes and compliance; there now needs to be a creative, collaborative and commercial mindset in order to remain competitive.
Greater public scrutiny of the environmental, social and ethical impact of pharmaceutical operations is also changing how organisations need to do business. Corporate social responsibility has taken on greater significance than ever before, requiring stakeholders to learn a new set of skills that have traditionally been seen as ‘soft’ or peripheral to the often life-saving work taking place in labs around the world.
At Primeast we believe the key to success for pharmaceutical companies is clear purpose + robust process + complementary behaviours. Over the last 30 years we’ve been working with global organisations to develop these three crucial criteria, focusing on the key areas of leadership, teamwork, and organisational development and change. With trained facilitators across the globe, we deliver bespoke interventions that are specifically targeted to address a company’s unique challenges.
We can help if you need to:
To find out more about how we can prepare your organisation for the future, please contact us.
Ivan Diaz-Padilla, MD, PhD, Global Clinical Leader, Novartis Oncology Clinical Development, Switzerland
I would like to congratulate the Education Office for having these sort of trainings (Emotional Intelligence). They should be a “must” in Novartis, and (Primeast Senior Consultant) Dave Levine is an amazing coach and facilitator.